rs375524303
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_000531.6(OTC):c.1005+11A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000063 in 1,207,023 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 24 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000531.6 intron
Scores
Clinical Significance
Conservation
Publications
- ornithine carbamoyltransferase deficiencyInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| OTC | NM_000531.6 | c.1005+11A>T | intron_variant | Intron 9 of 9 | ENST00000039007.5 | NP_000522.3 | ||
| OTC | NM_001407092.1 | c.1005+11A>T | intron_variant | Intron 11 of 11 | NP_001394021.1 | |||
| OTC | XM_017029556.2 | c.*149A>T | downstream_gene_variant | XP_016885045.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.0000445  AC: 5AN: 112279Hom.:  0  Cov.: 23 show subpopulations 
GnomAD2 exomes  AF:  0.0000983  AC: 18AN: 183143 AF XY:  0.0000887   show subpopulations 
GnomAD4 exome  AF:  0.0000649  AC: 71AN: 1094744Hom.:  0  Cov.: 29 AF XY:  0.0000639  AC XY: 23AN XY: 360214 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000445  AC: 5AN: 112279Hom.:  0  Cov.: 23 AF XY:  0.0000290  AC XY: 1AN XY: 34427 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency    Uncertain:1Benign:1 
This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: BS2. -
- -
Global developmental delay;C5574662:Hyperammonemia    Uncertain:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at